Tema Oncology ETFCANCETF
13F holders, Q1 2025 (March 31)6holders +3
4new positions
1sold out
$28.47avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, up 3 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were Thrivent Financial for Lutherans ($3.6M), Jane Street Group, LLC ($213K) and Osaic Holdings, Inc. ($9K).
- Company
- Tema Oncology ETF
- Filed as
- TEMA ETF TRUST (Q1 2025)
- CUSIP
- 87975E701
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $228K |
| Exits | 1 | $49 |
All 13F filers, Q4 2024 → Q1 2025: 9,472 shares bought and 391,645 shares sold, net −382,173 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Thrivent Financial for Lutherans | 0.01% | Reduce -75.6% | 126,194 | $3.6M |
| Jane Street Group, LLC | 0.00% | New | 8,829 | $213K |
| Osaic Holdings, Inc. | 0.00% | New | 370 | $9K |
| Harbour Investments, Inc. | 0.00% | No change | 316 | $8K |
| UBS Group AG | 0.00% | New | 223 | $5K |
| Principal Securities, Inc. | 0.00% | New | 50 | $1K |
"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.